Identification of a Resilient Group Against Acute Kidney Injury in Septic Shock
Overview
This study identified a subset of septic shock patients exhibiting resilience to acute kidney injury (AKI) despite significant kidney stress. Using biomarkers TIMP-2•IGFBP7 and KIM-1 alongside KDIGO criteria, researchers defined an AKI-resistant group and compared their outcomes to patients with AKI and those at reduced risk.
Background
Acute kidney injury is a frequent and serious complication in critically ill patients, especially those with sepsis, where it occurs in 40–50% of cases and significantly increases mortality. Current diagnostic criteria rely on functional loss, but biomarkers such as KIM-1 and the product of TIMP-2 and IGFBP7 ([TIMP-2]•[IGFBP7]) have emerged as sensitive indicators of kidney injury and stress. Identifying patients who resist AKI despite high kidney stress could provide insights into protective mechanisms and improve clinical management.
Data Highlights
Group
Criteria
Biomarker Levels
AKI Status
Reduced Risk
[TIMP-2]•[IGFBP7] ≤ 1.0 (ng/mL)2/1000
Low kidney stress
No AKI
AKI-Resistant
[TIMP-2]•[IGFBP7] > 1.0, KIM-1 ≤ 2 ng/mL, No KDIGO AKI
High stress, no injury
No AKI
AKI
[TIMP-2]•[IGFBP7] > 1.0, KIM-1 > 2 ng/mL or KDIGO AKI
High stress and injury
AKI present
Key Findings
Approximately 573 septic shock patients had adequate urine samples for biomarker analysis at 6 hours post-resuscitation.
AKI resistance was defined by elevated [TIMP-2]•[IGFBP7] (>1.0) indicating kidney stress, absence of clinical AKI by KDIGO criteria, and low KIM-1 (≤2 ng/mL) indicating no subclinical injury.
The AKI-resistant group demonstrated kidney stress without progression to injury or clinical AKI.
Patients with AKI resistance had distinct baseline characteristics compared to those with AKI or reduced risk, suggesting inherent resilience factors.
Survival at 30 days and ICU length of stay were primary outcomes assessed to evaluate clinical relevance of AKI resistance.
Clinical Implications
Recognizing patients who exhibit AKI resistance despite significant kidney stress may help clinicians identify individuals with protective mechanisms against kidney injury. Biomarker-guided stratification using [TIMP-2]•[IGFBP7] and KIM-1 can improve early risk assessment and potentially guide personalized interventions in septic shock. This approach may also inform future therapeutic development targeting resilience pathways.
Conclusion
The study successfully identified a resilient subgroup of septic shock patients who withstand acute kidney injury despite high kidney stress, highlighting the potential for biomarker-driven risk stratification and new avenues for understanding AKI pathophysiology.
References
ProCESS Trial Investigators 2014 -- Protocolized Care for Early Septic Shock
KDIGO Clinical Practice Guideline 2012 -- Acute Kidney Injury Definition and Staging
Bihorac et al. 2014 -- Validation of [TIMP-2]•[IGFBP7] as AKI Biomarkers
Vaidya et al. 2010 -- Kidney Injury Molecule-1 as a Biomarker
